Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2006-08-15
2006-08-15
Landsman, Robert S. (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C530S402000, C424S085200, C536S023500, C435S069100, C435S471000
Reexamination Certificate
active
07091319
ABSTRACT:
The present invention relates to fusion molecules composed of human interleukin-3 (hIL-3) variant or mutant proteins (muteins) functionally joined to a second colony stimulating factor (CSF), cytokine, lymphokine, interleukin or IL-3 variant. These hIL-3 variants contain amino acid substitutions and may also have amino acid deletions at both the N- and C-termini. The invention also relates to pharmaceutical compositions containing the fusion molecules and methods for using them.
REFERENCES:
patent: 4438032 (1984-03-01), Golde et al.
patent: 4810643 (1989-03-01), Souza
patent: 4877729 (1989-10-01), Clark et al.
patent: 4959455 (1990-09-01), Clark et al.
patent: 4999291 (1991-03-01), Souza
patent: 5032395 (1991-07-01), Clark et al.
patent: 5073627 (1991-12-01), Curtis et al.
patent: 5108910 (1992-04-01), Curtis et al.
patent: 5218092 (1993-06-01), Sasaki et al.
patent: 5376367 (1994-12-01), Williams
patent: 5516512 (1996-05-01), Dorssers et al.
patent: A 85306827.8 (1986-06-01), None
patent: A 89106339.8 (1989-10-01), None
patent: 4-63595 (1992-02-01), None
patent: WO 88/05469 (1988-07-01), None
patent: WO 90/01039 (1990-02-01), None
patent: WO 90/12877 (1990-11-01), None
patent: WO 91/02754 (1991-03-01), None
patent: WO 92/04455 (1992-03-01), None
patent: WO 92/06166 (1992-04-01), None
patent: 93/07171 (1993-04-01), None
patent: WO 94 12638 (1994-06-01), None
patent: WO 94 12639 (1994-06-01), None
Dorssers, L.C.J., et al. (1991) J. Biol. Chem. 266: 21310-17.
Olins, P.O., et al. (1995) J. Biol. Chem. 270: 23754-60.
Fojo et al.,Biochem.vol. 17—No. 15:3109 (1978).
Park et al.,Biotech, vol. 11:Nov. (1993).
Curtis et al.,Proc. Natl. Acad. Sci. USA 88:5809 (1991).
Williams et al., Cancer 67:2705-2707 (1991).
Welch et al., Exp. Hem 21:647-655 (1993).
Abrams Mark Allen
Bauer S. Christopher
Braford-Goldberg Sarah Ruth
Caparon Marie Helena
Easton Alan Michael
Landsman Robert S.
Winstead Sechrest & Minick PC
LandOfFree
IL-3 variant hematopoiesis fusion protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IL-3 variant hematopoiesis fusion protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-3 variant hematopoiesis fusion protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3685780